Subscribe to Newsletter


Reset Filter
You have a filtered search result

78 search results for ‘*’

Business & Regulation Profession

The Power List: Nominations to Close Shortly

| Stephanie Vine

Get your pharma heroes nominated by January 12!

Discovery & Development Drug Delivery

MIA and Potent Plants

| Jamie Irvine | 2 min read

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Manufacture Advanced Medicine

Notes, Quotes, and Anecdotes: Words of Wisdom from 2023

| Rob Coker | 5 min read

A selection of some of the most poignant words spoken by interviewees this year

Business & Regulation Quality & Compliance

The FDA Investigates T-Cell Malignancies in CAR-T Therapy

| Jamie Irvine | 4 min read

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Discovery & Development Drug Delivery

One Vaccine to Rule Them All

| Jamie Irvine | 2 min read

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

Manufacture Advanced Medicine

The Future Awakens

| Sponsored by Eppendorf, Millipore Sigma, Thermo Fisher Scientific & Miltenyi Biotec

Experts in the cell and gene therapy space are excited about things to come. After all, these are the pioneers of a burgeoning field of medicine.

Manufacture Facilities

Uniting a Cell and Gene Kingdom

| Jamie Irvine | 2 min read

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Manufacture Advanced Medicine

Reactions to the UK’s Approval of a CRISPR Medicine

| Stephanie Vine | 3 min read

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

Manufacture Advanced Medicine

The World’s First CRISPR-Based Therapeutic Approval

| Stephanie Vine | 3 min read

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Discovery & Development Drug Discovery

Opiate Dreams and Nightmares

| Jamie Irvine | 3 min read

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine